Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Targovax CEO steps down, current CFO takes the role
November 2, 2016 Off

Targovax CEO steps down, current CFO takes the role

By Dino Mustafić

Targovax CEO has stepped down, current CFO takes the role

European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech
November 2, 2016 Off

European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech

By Dino Mustafić

European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech

November 2, 2016 Off

India’s Ajanta gets green light for its high blood pressure generic

By Dino Mustafić

Ajanta Pharma has gotten US FDA’s approval to launch its high blood pressure tablets Amlodipine

Shire doubles third quarter revenues, operates with net loss in Q3
November 2, 2016 Off

Shire doubles third quarter revenues, operates with net loss in Q3

By Dino Mustafić

Shire doubles third quarter revenues, operates with net loss in Q3

November 2, 2016 Off

India’s Koanna gets UK’s MHRA OK for Imatinib tablets

By Dino Mustafić

India’s Koanna gets marketing approval from MHRA for Imatinib tablets

November 2, 2016 Off

Chronix Biomedical looking to distinguish prostate cancer from BPH and prostatitis

By Dino Mustafić

Chronix Biomedical looking to distinguish prostate cancer from BPH and prostatitis

Pfizer to discontinue two ongoing cardiovascular studies
November 1, 2016 Off

Pfizer to discontinue two ongoing cardiovascular studies

By Dino Mustafić

Pfizer announced today the discontinuation of the global clinical development program for bococizumab…

Allergan closes down Tobira purchace
November 1, 2016 Off

Allergan closes down Tobira purchace

By Dino Mustafić

Allergan has completed the acquisition of Tobira Therapeutics

Novartis gets FDA Priority Review for first-line treatment of advanced breast cancer
November 1, 2016 Off

Novartis gets FDA Priority Review for first-line treatment of advanced breast cancer

By Dino Mustafić

Novartis gets FDA Priority Review for first-line treatment of HR+/HER2-advanced breast cancer

USFDA opens door to $30M market for India’s Strides Shasun’s HIV-1 infection tablets
November 1, 2016 Off

USFDA opens door to $30M market for India’s Strides Shasun’s HIV-1 infection tablets

By Dino Mustafić

India’s Strides Shasun Limited has received approval from the USFDA for Abacavir Tablets

Posts pagination

Previous 1 … 3,552 3,553 3,554 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine